The Chemours Company
CC
$16.92
-$1.07-5.95%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.13% | -0.86% | 3.93% | 0.44% | -3.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.13% | -0.86% | 3.93% | 0.44% | -3.75% |
| Cost of Revenue | 7.04% | 3.11% | 7.30% | 5.01% | -5.45% |
| Gross Profit | -40.00% | -17.83% | -9.74% | -16.90% | 3.92% |
| SG&A Expenses | -38.60% | -22.22% | 17.11% | -11.03% | 28.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.93% | 0.36% | 8.36% | 3.06% | -1.90% |
| Operating Income | -60.29% | -14.75% | -44.62% | -26.67% | -29.17% |
| Income Before Tax | -- | 259.38% | -478.26% | -100.00% | 100.00% |
| Income Tax Expenses | -141.67% | -- | 1,222.22% | -75.00% | 122.64% |
| Earnings from Continuing Operations | -416.67% | 287.50% | -733.33% | -107.41% | 25.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -408.33% | 287.50% | -735.00% | -107.41% | 33.33% |
| EBIT | -60.29% | -14.75% | -44.62% | -26.67% | -29.17% |
| EBITDA | -7.75% | -6.15% | -25.49% | -13.61% | -16.47% |
| EPS Basic | -406.12% | 286.67% | -731.47% | -107.37% | 33.75% |
| Normalized Basic EPS | -447.73% | -27.84% | -82.87% | -55.19% | -68.98% |
| EPS Diluted | -412.48% | 281.41% | -751.28% | -108.33% | 38.34% |
| Normalized Diluted EPS | -447.73% | -28.05% | -82.79% | -54.89% | -68.98% |
| Average Basic Shares Outstanding | 0.43% | 0.42% | 0.55% | 0.59% | 0.65% |
| Average Diluted Shares Outstanding | 0.43% | 0.72% | 0.08% | -0.09% | 0.65% |
| Dividend Per Share | -65.00% | -65.00% | -65.00% | 0.00% | 0.00% |
| Payout Ratio | 0.92% | 1.18% | -1.06% | -14.50% | -0.46% |